Salma M. Aldallal. “Ofatumumab As an Emerging Treatment Option for Chronic Lymphocytic Leukaemia Patients”. Research Highlights in Disease and Health Research Vol. 2, Feb. 2023, pp. 10-24, doi:10.9734/bpi/rhdhr/v2/9253F.